Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications

Area of Science:

• Cardiovascular Medicine
• Hematology
• Thrombosis Research

Background:

• Spontaneous platelet aggregation (SPA) is a phenomenon observed in certain vascular conditions.
• Understanding the clinical relevance and underlying mechanisms of SPA is crucial for managing vascular insufficiency.

Purpose of the Study:

• To investigate the clinical implications of spontaneous platelet aggregation (SPA) in patients with vascular insufficiency.
• To elucidate the mechanisms involved in SPA and identify potential therapeutic targets.

Main Methods:

• Studied 150 normal subjects, 22 patient controls, and 130 patients with vascular insufficiency.
• Assessed SPA positivity in various conditions including transient ischemic attacks, stable angina, acute myocardial infarction, and acute peripheral arterial insufficiency.
• Investigated the inhibitory effects of various agents (aspirin, 2-chloroadenosine, prostaglandin E1, apyrase, heparin, hirudin) on SPA in vitro and in vivo.

Main Results:

• SPA was positive in a significant percentage of patients with vascular insufficiency (e.g., 54% with transient ischemic attacks, 80% with acute peripheral arterial insufficiency).
• SPA was inhibited by aspirin in vivo and competitively by aspirin, 2-chloroadenosine, prostaglandin E1, or apyrase in vitro at low concentrations.
• High concentrations of heparin or hirudin were required for inhibition; platelet-poor plasma from SPA-positive patients did not induce aggregation in normal platelets.

Conclusions:

• SPA is a clinically relevant marker associated with vascular insufficiency.
• SPA can be effectively inhibited by antiplatelet agents like aspirin and dipyridamole.
• Treatment with aspirin and dipyridamole led to clinical improvement in patients with acute peripheral arterial insufficiency by preventing SPA.